XML 41 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Nov. 30, 2019
Nov. 30, 2018
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating Expenses        
Research and development, net (Note 12) 1,278,172 792,111 3,246,246 2,924,483
General and administrative (Note 12) 1,825,813 1,971,847 5,447,056 6,721,796
Depreciation and amortization (Notes 4 and 5) 219,628 155,053 585,367 366,710
Interest and other finance costs (Note 15) 693,027 14,883 1,817,091 41,117
Interest income (171,274) 0 (363,565) 0
Foreign exchange loss (gain) 5,533 (20,132) 15,297 (72,404)
Total expenses 3,850,899 2,913,762 10,747,492 9,981,702
Net loss (3,850,899) (2,913,762) (10,747,492) (9,981,702)
Other comprehensive loss        
Foreign currency translation adjustment 7,552 (91,249) (30,133) (202,838)
Comprehensive loss $ (3,843,347) $ (3,005,011) $ (10,777,625) $ (10,184,540)
Loss per share        
Basic and diluted $ (.10) $ (0.09) $ (0.29) $ (.30)
Weighted average common shares outstanding        
Basic and diluted 39,133,627 33,805,706 37,404,165 33,792,293